Diastolic dysfunction in arterial hypertension

Journal of Clinical Hypertension

Volumn 3, Issue 1, 2001, Pages 22-27

  De Simone, Giovanni ^a   Palmieri, Vittorio ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; NEUROHORMONE; NIFEDIPINE; NITRIC OXIDE DONOR;

ANTIHYPERTENSIVE THERAPY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; HEART AFTERLOAD; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE RELAXATION; HEART WORK; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OBESITY; REVIEW;

EID: 0034962369     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2001.00827.x     Document Type: Review

References (46)

1. The heart in hypertension
2. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events
3. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
4. Left ventricular mass and incidence of coronary heart disease in an elderly cohort
5. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
6. The progression from hypertension to congestive heart failure
7. From "compensatory" hypertensive left ventricular hypertrophy to heart failure: Is the transition so dramatic?
8. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure
9. The Sixth Report of the Joint National Committee
10. Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension
11. Relation of left ventricular diastolic properties to systolic function in arterial hypertension
12. Myocardial relaxation: Effects of preload on the time course of isovolumic relaxation
13. Congestive heart failure in patients with normal left ventricular systolic function: A manifestation of diastolic dysfunction
14. Relaxation and diastole of the heart
15. Evidence of incomplete left ventricular relaxation in the dog: Prediction from the time constant for isovolumic pressure fall
16. Mechanical determinants of the rate of isotonic lengthening in rat left ventricular myocardium
17. Loading determinants of isovolumic pressure fall in closed-chest dogs
18. Echocardiographic Doppler evaluation of left ventricular diastolic function
19. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure
20. Active and passive components of ventricular diastole: Is it possible to consider their interaction avoiding confusion?
21. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
22. Determinants of left ventricular filling and of the diastolic pressure-volume relation
23. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation
24. Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders
25. Isovolumic relaxation time varies predictably with its time constant and aortic and left atrial pressures: Implication for the noninvasive evaluation of ventricular relaxation
26. Load dependent left ventricular relaxation in conscious dogs
27. Influence of systolic pressure profile on rate of left ventricular pressure fall
28. Left ventricular filling pattern in uncomplicated obesity
29. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity
30. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure-overload hypertrophy
31. Cardiac interstitium in health and disease: The fibrillar collagen network
32. Pulmonary venous flow and mitral inflow velocity pattern in uncomplicated obesity: Evidence for late diastolic dysfunction
33. Effect of the geometry of the left ventricle on the calculation of ejection fraction
34. Measurement of left ventricular function by mid-wall fractional shortening in human hypertension
35. [Ventricular systolic function. The intramyocardial mechanics and the indices of systolic ejection: The different physiological and clinical significance]
36. Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease
37. Left ventricular chamber and wall mechanics in the presence of concentric geometry
38. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy
39. Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension
40. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (the PRESERVE study)
41. Diastolic heart failure
42. Impact of anti-hypertensive therapy on left ventricular mass, geometry and hemodynamics in patients with left ventricular hypertrophy. The PRESERVE trial
43. Doppler assessment of diastolic function comes of age
44. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action
45. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction
46. Cardiac hypertrophy: The consequences for diastole